These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment of arsenical keratosis with etretinate. Sharma SC; Simpson NB Acta Derm Venereol; 1983; 63(5):449-52. PubMed ID: 6197851 [TBL] [Abstract][Full Text] [Related]
3. [Use of etretinate in the treatment of lingua villosa nigra]. Rusciani L; Posteraro R G Ital Dermatol Venereol; 1987 Sep; 122(9):477-8. PubMed ID: 3679304 [No Abstract] [Full Text] [Related]
4. Treatment of hyperkeratotic conditions of the legs with etretinate. English JS; Roberts DT J Am Acad Dermatol; 1984 Jun; 10(6):1067-8. PubMed ID: 6736328 [No Abstract] [Full Text] [Related]
5. Etretinate in the treatment of disseminated porokeratosis of Mibelli. Hacham-Zadeh S; Holubar K Int J Dermatol; 1985 May; 24(4):258-60. PubMed ID: 4008157 [TBL] [Abstract][Full Text] [Related]
6. Response of PUVA-induced keratoses to etretinate. Hudson-Peacock MJ; Angus B; Farr PM J Am Acad Dermatol; 1996 Jul; 35(1):120-3. PubMed ID: 8682951 [No Abstract] [Full Text] [Related]
7. [Progressive symmetric erythrokeratodermia. Report of a case with delayed onset treated by etretinate]. Borbujo Martinez J; Casado Jimenez M; Jimenez Acosta F; Almagro Sanchez M; Martinez Gomez W; Soto Melo J Med Cutan Ibero Lat Am; 1988; 16(3):236-8. PubMed ID: 2974108 [TBL] [Abstract][Full Text] [Related]
8. Treatment of disseminated superficial actinic porokeratosis with a new aromatic retinoid (Ro 10-9359). Kariniemi AL; Stubb S; Lassus A Br J Dermatol; 1980 Feb; 102(2):213-4. PubMed ID: 7387874 [No Abstract] [Full Text] [Related]
9. Severe disorders of keratinization: effects of treatment with Tigason (etretinate). Marks R; Finlay AY; Holt PJ Br J Dermatol; 1981 Jun; 104(6):667-73. PubMed ID: 7248177 [TBL] [Abstract][Full Text] [Related]
10. Patients' acceptance of etretinate therapy. A retrospective survey of long-term etretinate therapy in chronic keratotic and pustular skin diseases. Christiansen JV; Holm P; Reymann F; Thestrup-Pedersen K Dermatologica; 1984; 168(3):122-6. PubMed ID: 6714503 [TBL] [Abstract][Full Text] [Related]
11. Hyperkeratotic porokeratosis (Mibelli) with psoriasis--response to an aromatic retinoid. Beer WE; Smith NP Clin Exp Dermatol; 1984 Sep; 9(5):509-13. PubMed ID: 6488582 [No Abstract] [Full Text] [Related]
12. [Tigason in hyperkeratosis lenticularis perstans (HLP)--a case report]. Gabrielsen TO Z Hautkr; 1986 Feb; 61(4):214-7. PubMed ID: 3962407 [TBL] [Abstract][Full Text] [Related]
13. Keratosis lichenoides chronica with prominent telangiectasia: response to etretinate. David M; Filhaber A; Rotem A; Katzenelson-Weissman V; Sandbank M J Am Acad Dermatol; 1989 Nov; 21(5 Pt 2):1112-4. PubMed ID: 2808843 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of hyperkeratotic dermatoses with an oral aromatic retinoid (Ro 10-9359)]. Pehamberger H; Esca SA; Holubar K Z Hautkr; 1980 Jan; 55(2):68-78. PubMed ID: 7405336 [TBL] [Abstract][Full Text] [Related]
15. Etretinate in treatment of actinic keratosis. A double-blind crossover study. Moriarty M; Dunn J; Darragh A; Lambe R; Brick I Lancet; 1982 Feb; 1(8268):364-5. PubMed ID: 6120350 [TBL] [Abstract][Full Text] [Related]
16. Monilethrix treated with oral retinoids. de Berker D; Dawber RP Clin Exp Dermatol; 1991 May; 16(3):226-8. PubMed ID: 1934581 [TBL] [Abstract][Full Text] [Related]
17. Retinoids in psoriasis and disorders of keratinization. Fritsch PO J Am Acad Dermatol; 1992 Dec; 27(6 Pt 2):S8-14. PubMed ID: 1460124 [TBL] [Abstract][Full Text] [Related]
18. Bazex paraneoplastic acrokeratosis: a case report and response to Tigason. Wishart JM Br J Dermatol; 1986 Nov; 115(5):595-9. PubMed ID: 3790436 [TBL] [Abstract][Full Text] [Related]